Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

TAMPA, Fla.  – Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway. This type of mutation makes the cancer more aggressive and difficult to treat. Researchers at Moffitt Cancer Center are hoping to change that. In a new study published in Cancer Research, the team discovered a new treatment approach that may help this group of patients.

Full Story

Related posts

UCF Researchers Design Custom-Fit 3D-Printed Medical Devices for Infants

UCF researchers detail how they used data from three unidentified pediatric cases from Nemours Children’s…

FSU: Airbnb’s explosive growth jolts hotel industry’s bottom line

New research from Florida State University finds Airbnb’s exponential growth worldwide is devouring an increasing…

FIU: Researchers warn teens about potential harms of vaping

FIU psychologists Elisa Trucco and Matthew Sutherland are educating students, school personnel and parents about…